Cleared Traditional

K091358 - ECSCOPE 100

K091358 is an FDA 510(k) clearance for ECSCOPE 100, manufactured by Dyansys, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 20-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2009
Decision
20d
Days
Class 2
Risk

K091358 is an FDA 510(k) clearance for the ECSCOPE 100. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Dyansys, Inc. (Burlingame, US). The FDA issued a Cleared decision on May 28, 2009 after a review of 20 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dyansys, Inc. devices

FDA 510(k) Submission Details - K091358

510(k) Number K091358 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 2009
Decision Date May 28, 2009
Days to Decision 20 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
105d faster than avg
Panel avg: 125d · This submission: 20d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 280
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K091358.
PC ECG, MODEL SE-1010
K092010 · Edan Instruments, Inc. · Oct 2009
SMART ECG SERIES ELECTROCARDIOGRAPH, MODELS SE-3, SE-300A AND 300B, SE-6, SE-600, SE-12, SE-12 EXPRESS AND SE-1200
K091513 · Edan Instruments, Inc. · Jul 2009
SE-601 SERIES ELECTROCARDIOGRAPH
K090367 · Edan Instruments, Inc. · Jun 2009
SURSIGNS VS2 VITAL SIGNS MONITOR, SURESIGNS VS3 VITAL SIGNS MONITOR, SURESIGNS VM SERIES PATIENT MONITORS
K090483 · Philips Medical Systems · Mar 2009
MORTARA ELI 350 ELECTROCARDIOGRAPH
K082946 · Mortara Instrument, Inc. · Dec 2008
HANDHELD ECG MONITOR, MODEL MD100
K080933 · Beijing Choice Electronic Technololgy Co., Ltd. · Sep 2008